Back to search

Article

EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening

2023-10-09

Abstract excerpt

<title>Abstract</title> <p>Background. New drugs to tackle the next pathway or mutation fueling cancer are constantly proposed, but 97% of them are doomed to fail in clinical trials, largely because they are identified by cellular or in silico screens that cannot predict their in vivo effect. Methods. We screened an Adeno-Associated Vector secretome library (> 1000 clones) directly <italic>in vivo</italic> in a m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32b1b9c7-cc7d-58dd-b07b-33b2aac0acf5
DOI
10.21203/rs.3.rs-3395702/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screeningDOI 10.21203/rs.3.rs-3395702/v1
A platform of functional studies of ESCC-associated gene mutations identifies the roles of TGFBR2 in ESCC progression and metastasis.Semantic proximity
Targeting CXADR-mediated AKT signaling suppresses tumorigenesis and enhances chemotherapy efficacy in Ewing sarcomaSemantic proximity
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progressionSemantic proximity
EMID1: a multifunctional molecule identified in a murine model for the invasion- independent metastasis pathwaySemantic proximity
A Rational Drug Combination Design to Inhibit Epithelial-Mesenchymal Transition in a Three-Dimensional MicroenvironmentSemantic proximity
Simultaneous screening of overexpressed genes in breast cancer for oncogenic drivers and tumor dependenciesSemantic proximity
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceSemantic proximity
An in vivo screening system to identify tumorigenic genes.Semantic proximity
Genomic analyses identify key molecules and biological processes in cancer-derived-extracellular vehicles treated musclesSemantic proximity
Genetic Ablation and Multi-Omics Profiling Reveal CEP55 as a Key Driver of Tumorigenesis in Diverse Cancer ModelsSemantic proximity
Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceSemantic proximity
Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.